Articles > Reference > Dictionaries, Thesauruses, Pictures, and Press Releases > PR Newswire Europe press releases > February 2007

Article: Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies.

Article from:
PR Newswire Europe
Article date:
February 5, 2007
Copyright

MADISON, New Jersey, February 5 /PRNewswire/ --

- Wyeth - World's Fourth Largest Biopharmaceutical Company -

- Builds on Commitment to Innovation in Hemophilia

Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Nautilus Biotech in Evry, France, today announced the signing of a research collaboration and license agreement to discover and develop novel recombinant Factor IX proteins for the treatment of hemophilia B. These extended half-life proteins will be designed to enhance patient convenience as they will reduce the number and frequency of treatments needed.

As part of the agreement, Nautilus Biotech will apply its ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: WYETH PHARMACEUTICALS, NAUTILUS ...
AsiaPulse News;  February 5, 2007 ;     700+ words ... ... below.) Wyeth Pharmaceuticals and Nautilus Biotech Announce ... Hemophilia Wyeth Pharmaceuticals, a division ... Wyeth, and Nautilus Biotech in Evry ... Business Unit at Wyeth Pharmaceuticals. Under the ... research. Nautilus Biotech will receive ...

Article: Nautilus Biotech Begins Phase I Clinical Trial in ...
PR Newswire;  April 2, 2007 ;     700+ words ... ... Nautilus Biotech Nautilus Biotech is a drug discovery ... 15 per annum. Nautilus Biotech has created a portfolio ... collaboration with Wyeth Pharmaceuticals) and HMGB1 (in ... Therapeutics). Nautilus Biotech has established ...

Article: Nautilus Biotech Closes EUR8.4 Million (US$11.3 ...
PR Newswire Europe;  April 30, 2007 ;     700+ words ... ... Nautilus Biotech Nautilus Biotech is a leading biotechnology ... 15% per annum. Nautilus Biotech has created a portfolio ... collaboration with Wyeth Pharmaceuticals) and HMGB1-BoxA ... Therapeutics). Nautilus Biotech has established ...

Article: Nautilus Biotech Announces IND Filing for its ...
PR Newswire;  October 10, 2006 ;     700+ words ... ... PARIS, October 10 /PRNewswire/ -- Nautilus Biotech has announced that it has submitted ... been designed and developed using Nautilus Biotech's proprietary technology for protein ... products into the clinic." said Nautilus Biotech CEO, Manuel Vega. "We believe BELEROFON ...

Article: Nautilus Biotech and Creabilis Therapeutics Achieve ...
PR Newswire;  November 14, 2006 ;     700+ words ... ... Italy, November 14 /PRNewswire/ -- Nautilus Biotech SA and Creabilis Therapeutics SpA ... related diseases in animal models. Nautilus Biotech and Creabilis Therapeutics entered ... proprietary protein engineering technology, Nautilus Biotech created a series of single amino acid ...

Article: NAUTILUS BIOTECH S.A.
PR Newswire;  September 14, 2001 ;     696 words ...NAUTILUS BIOTECH S.A. FILES A KEY PATENT APPLICATION IN THE US PR Newswire ... September 14. This press release is transmitted on behalf of Nautilus Biotech S.A. Paris - Nautilus Biotech S.A. has filed a key patent application in the US ...

Article: Nautilus Biotech Announces Progress on ...
PR Newswire;  March 23, 2004 ;     700+ words ... ... France, March 23 /PRNewswire/ -- Nautilus Biotech today announced the successful completion ... including IFN beta (PR Feb 27, 2004, 'Nautilus Biotech announces progress on improved Interferon ... said Nautilus CEO, M Vega. About Nautilus Biotech Using its proprietary technologies ...

Article: Nautilus Biotech Optimizes the AAV Rep Protein to ...
PR Newswire;  September 21, 2001 ;     700+ words ... ... proprietary directed evolution technology, Nautilus Biotech has developed a collection of proprietary ... enzymes, R&D reagents) areas. Nautilus Biotech intends to leverage its platform Biomics ... director of corporate development. About Nautilus Biotech: Nautilus ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives